The bill aims to reduce barriers to the use of genetic and genomic testing, including for children on Medicaid with a suspected genetic disease.

Research on phages in CRISPR-Cas9-containing Escherichia coli indicated that pressure exerted by the bacterial defense system can boost phage mutation frequency.

London-based LGC said that the acquisition increases its exposure to the next-generation sequencing and gene editing markets.

At AGBT, researchers described applications for rapid pathogen ID; evaluating DNA, RNA, and gene expression in one assay; and understanding tumor heterogeneity.

The company plans to launch a single-cell CNV assay, a single cell ATAC-seq assay, and a single-cell feature barcoding assay later this year.

The $649 NGS test screens for 193 disorders, can be ordered online, and is designed to supplement standard state newborn screening services. 

The company's new effort, DigitalMe, has recruited more than 5,000 participants so far, tracking patient health reports alongside genomics and repeat blood biomarker measurements.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

This application note demonstrates that:

• The new Applied Biosystems SeqStudio Genetic Analyzer generates high-quality data from multiplex ligation–dependent probe amplification (MLPA) assays developed by MRC-Holland.

• The SeqStudio Genetic Analyzer provides fast and efficient results; each run cycle accommodates 4 MLPA reaction samples and can be completed within 45 min.

Jan
10
Sponsored by
Biognosys

Protein concentrations are determined by the levels of their coding mRNAs, by their translation rates, and by protein turnover. However, how much does each of these processes contribute to observed protein levels? Does a weak correlation of protein and mRNA levels indicate poor quality of the data? Or does it imply that post-transcriptional processes substantially contribute fine-tuning protein levels? The webinar will address these and related questions.